TDOC TELADOC HEALTH INC revenue, earnings and financials

For the quarter ended June 30, 2026, TELADOC HEALTH INC reported revenue of $607M (down 4.0% from a year earlier), net income of −$38.9M and diluted EPS of −$0.21; over the last four quarters revenue was $2.49B and net income −$177M; for the fiscal year ended December 2025 revenue was $2.53B, down 1.5% on the year before.

TDOC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $2.53B, gross profit n/a, operating income −$263M, net income −$200M (margin -7.9%), EPS −$1.14
• Fiscal year ended Dec 2024: revenue $2.57B, gross profit n/a, operating income −$1.02B, net income −$1.00B (margin -39.0%), EPS −$5.87
• Fiscal year ended Dec 2023: revenue $2.60B, gross profit n/a, operating income −$249M, net income −$220M (margin -8.5%), EPS −$1.34
• Fiscal year ended Dec 2022: revenue $2.41B, gross profit n/a, operating income −$13.7B, net income −$13.7B (margin -567.5%), EPS −$84.60
• Fiscal year ended Dec 2021: revenue $2.03B, gross profit n/a, operating income −$266M, net income −$429M (margin -21.1%), EPS −$2.73

TDOC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $607M (down 4.0% year over year), net income −$38.9M, EPS −$0.21
• Quarter ended Mar 31, 2026: revenue $614M (down 2.5% year over year), net income −$63.8M, EPS −$0.36
• Quarter ended Dec 31, 2025 (from the annual report): revenue $642M (up 0.3% year over year), net income −$25.1M, EPS −$0.14
• Quarter ended Sep 30, 2025: revenue $626M (down 2.2% year over year), net income −$49.5M, EPS −$0.28
• Quarter ended Jun 30, 2025: revenue $632M (down 1.6% year over year), net income −$32.7M, EPS −$0.19
• Quarter ended Mar 31, 2025: revenue $629M (down 2.6% year over year), net income −$93.0M, EPS −$0.53
• Quarter ended Dec 31, 2024 (from the annual report): revenue $640M (down 3.0% year over year), net income −$48.4M, EPS −$0.27
• Quarter ended Sep 30, 2024: revenue $641M (down 3.0% year over year), net income −$33.3M, EPS −$0.19
• Quarter ended Jun 30, 2024: revenue $642M (down 1.5% year over year), net income −$838M, EPS −$4.92
• Quarter ended Mar 31, 2024: revenue $646M (up 2.7% year over year), net income −$81.9M, EPS −$0.49
• Quarter ended Dec 31, 2023 (from the annual report): revenue $661M (up 3.6% year over year), net income −$28.9M, EPS −$0.17
• Quarter ended Sep 30, 2023: revenue $660M (up 8.0% year over year), net income −$57.1M, EPS −$0.35
• Quarter ended Jun 30, 2023: revenue $652M (up 10.1% year over year), net income −$65.2M, EPS −$0.40
• Quarter ended Mar 31, 2023: revenue $629M (up 11.3% year over year), net income −$69.2M, EPS −$0.42
• Quarter ended Dec 31, 2022 (from the annual report): revenue $638M (up 15.1% year over year), net income −$3.81B, EPS −$23.35
• Quarter ended Sep 30, 2022: revenue $611M (up 17.2% year over year), net income −$73.5M, EPS −$0.45
• Quarter ended Jun 30, 2022: revenue $592M (up 17.7% year over year), net income −$3.10B, EPS −$19.22
• Quarter ended Mar 31, 2022: revenue $565M (up 24.6% year over year), net income −$6.67B, EPS −$41.58
• Quarter ended Dec 31, 2021 (from the annual report): revenue $554M, net income −$11.0M, EPS −$0.03
• Quarter ended Sep 30, 2021: revenue $522M, net income −$84.3M, EPS −$0.53

TDOC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $294M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $294M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $350M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $189M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $194M, share buybacks n/a

TDOC balance sheet

• Jun 30, 2026: cash $774M, total assets $2.76B, total liabilities $1.45B, shareholders' equity $1.31B
• Mar 31, 2026: cash $751M, total assets $2.81B, total liabilities $1.47B, shareholders' equity $1.34B
• Dec 31, 2025: cash $781M, total assets $2.86B, total liabilities $1.47B, shareholders' equity $1.39B
• Sep 30, 2025: cash $726M, total assets $2.88B, total liabilities $1.49B, shareholders' equity $1.39B
• Jun 30, 2025: cash $680M, total assets $2.89B, total liabilities $1.47B, shareholders' equity $1.42B
• Mar 31, 2025: cash $1.19B, total assets $3.44B, total liabilities $2.02B, shareholders' equity $1.43B
• Dec 31, 2024: cash $1.30B, total assets $3.52B, total liabilities $2.03B, shareholders' equity $1.49B
• Sep 30, 2024: cash $1.24B, total assets $3.53B, total liabilities $2.02B, shareholders' equity $1.51B

What is TDOC's revenue?

TELADOC HEALTH INC reported $2.49B of revenue over its last four quarters, through June 30, 2026.

Is TDOC profitable?

No. TELADOC HEALTH INC lost $177M over the last four quarters.

What is TDOC's EPS?

Diluted earnings per share over the last four quarters were −$0.99; −$0.21 in the latest quarter.

TDOC ownership and insider trades · All stocks